Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
M. Edvinsson, M. Stenkvist Asplund, E. Hjelm & C. Nyström-Rosander. (2006) Chlamydophila pneumoniae in chronic rhinosinusitis. Acta Oto-Laryngologica 126:9, pages 952-957.
Read now
Read now
Judy Gnarpe, Håkan Gnarpe, Ingrid Gause-Nilsson, Per Lundborg, Bertil Steen. (2000) Seroprevalence of Antibodies to Chlamydia pneumoniae in Elderly People: A Two-decade Longitudinal and Cohort Difference Study. Scandinavian Journal of Infectious Diseases 32:2, pages 177-179.
Read now
Read now
GÖRan Falck, Ingemar Engstrand, Adel Gad, Judy Gnarpe, HÅKan Gnarpe & Aino Laurila. (1997) Demonstration of Chlamydia pneumoniae in Patients with Chronic Pharyngitis. Scandinavian Journal of Infectious Diseases 29:6, pages 585-589.
Read now
Read now
Articles from other publishers (19)
Lars Karlsson, Judy Gnarpe, David Bergqvist, Johan Lindbäck & Håkan Pärsson. (2009) The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms - A prospective randomized double-blind trial. Journal of Vascular Surgery 50:1, pages 23-29.
Crossref
Crossref
Mika Paldanius, Aini Bloigu, Marianne Alho, Maija Leinonen & Pekka Saikku. (2005)
Prevalence and Persistence of
Chlamydia pneumoniae
Antibodies in Healthy Laboratory Personnel in Finland
. Clinical and Vaccine Immunology 12:5, pages 654-659.
Crossref
Crossref
Roberto Ronchetti, Gian Luca Biscione, Francesco Ronchetti, Maria Paola Ronchetti, Susy Martella, Carlo Falasca, Carolina Casini, Mario Barreto & Maria Pia Villa. (2005) Why Chlamydia pneumoniae is associated with asthma and other chronic conditions? Suggestions from a survey in unselected 9 yr old schoolchildren. Pediatric Allergy and Immunology 16:2, pages 145-150.
Crossref
Crossref
Håkan G. Gnarpe & Judy A. Gnarpe. 2005. Chlamydia pneumoniae Infection and Disease. Chlamydia pneumoniae Infection and Disease
187
197
.
Liisa Törmäkangas, Hannu Alakärppä, Denise Bem David, Maija Leinonen & Pekka Saikku. (2004)
Telithromycin Treatment of Chronic
Chlamydia pneumoniae
Infection in C57BL/6J mice
. Antimicrobial Agents and Chemotherapy 48:10, pages 3655-3661.
Crossref
Crossref
Brian B. S. Vandahl, Svend Birkelund & Gunna Christiansen. (2004)
Genome and proteome analysis of
Chlamydia
. PROTEOMICS 4:10, pages 2831-2842.
Crossref
Crossref
Naoyuki Miyashita, Hiroshi Fukano, Koichiro Yoshida, Yoshihito Niki & Toshiharu Matsushima. (2003) Chlamydia pneumoniae infection in adult patients with persistent cough. Journal of Medical Microbiology 52:3, pages 265-269.
Crossref
Crossref
Brian Y.L. Wong, Judy Gnarpe, Koon K. Teo, E.Magnus Ohman, Connie Prosser, W.Brian Gibler, Anatoly Langer, Wei-Ching Chang & Paul W. Armstrong. (2002) Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes. American Heart Journal 144:6, pages 987-994.
Crossref
Crossref
Go¨ran Falck, Judy Gnarpe, Lars-Olof Hansson, Kurt Sva¨rdsudd & Håkan Gnarpe. (2002) Comparison of Individuals with and Without Specific IgA Antibodies to Chlamydia pneumoniae. Chest 122:5, pages 1587-1593.
Crossref
Crossref
Corinna Hermann, Kathrin Graf, Annemarie Groh, Eberhard Straube & Thomas Hartung. (2002)
Comparison of Eleven Commercial Tests for
Chlamydia pneumoniae
-Specific Immunoglobulin G in Asymptomatic Healthy Individuals
. Journal of Clinical Microbiology 40:5, pages 1603-1609.
Crossref
Crossref
I. Gustafsson, E. Hjelm & O. Cars. (2000)
In Vitro Pharmacodynamics of the New Ketolides HMR 3004 and HMR 3647 (Telithromycin) against
Chlamydia pneumoniae
. Antimicrobial Agents and Chemotherapy 44:7, pages 1846-1849.
Crossref
Crossref
JUDY Gnarpe & LINDA Lindquist. (2008)
A new DIG‐PCR‐EIA method for the detection of
Chlamydia pneumoniae
DNA in clinical samples
. APMIS 108:9, pages 626-632.
Crossref
Crossref
David L. Hahn. (1999) Chlamydia pneumoniae, asthma, and COPD: what is the evidence?. Annals of Allergy, Asthma & Immunology 83:4, pages 271-292.
Crossref
Crossref
P. J. Cook. (1999) Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma. Journal of Antimicrobial Chemotherapy 44:2, pages 145-148.
Crossref
Crossref
Heike M. Freidank, Philipp Losch, Heike Vögele & Margit Wiedmann-Al-Ahmad. (1999)
In Vitro Susceptibilities of
Chlamydia pneumoniae
Isolates from German Patients and Synergistic Activity of Antibiotic Combinations
. Antimicrobial Agents and Chemotherapy 43:7, pages 1808-1810.
Crossref
Crossref
Björn FagerbergJudy GnarpeHåkan GnarpeStefan AgewallJohn Wikstrand. (1999)
Chlamydia pneumoniae
but Not Cytomegalovirus Antibodies Are Associated With Future Risk of Stroke and Cardiovascular Disease
. Stroke 30:2, pages 299-305.
Crossref
Crossref
D. L. Hahn & L. Allegra. 1999. Chlamydia pneumoniae. Chlamydia pneumoniae
114
123
.
P. Saikku. 1999. Chlamydia pneumoniae. Chlamydia pneumoniae
96
113
.
R. P. Verkooyen, D. Willemse, S. C. A. M. Hiep-van Casteren, S. A. Mousavi Joulandan, R. J. Snijder, J. M. M. van den Bosch, H. P. T. van Helden, M. F. Peeters & H. A. Verbrugh. (1998)
Evaluation of PCR, Culture, and Serology for Diagnosis of
Chlamydia pneumoniae
Respiratory Infections
. Journal of Clinical Microbiology 36:8, pages 2301-2307.
Crossref
Crossref